Memorial Sloan Kettering Cancer Center 7th Annual MSK Symposium on Lymphoma 2023

Description

+ Include: 37 videos + 31 pdfs, size: 15.6 GB

+ Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma

+ Sample video: contact me for sample video

+ Information:

We are excited to welcome attendees back to New York City for the 7th Annual MSK Symposium on Lymphoma. This Symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes.

This year, we will address the clinical management of the most frequent lymphoma entities and will feature focused sessions related to new families of drugs being developed in these areas as well as in less common presentations. Faculty will present those and then discuss, during a panel, how to best approach patients’ situations. We will also cover, in a special session, recent advances in the biology of lymphoma and how these will translate to innovative therapeutic interventions

Highlights of this year’s hybrid program include:

FRIDAY, MAY 5

Afternoon Breakout Sessions – Two concurrent breakout sessions will be held on Friday afternoon. Selection for the breakout sessions must be made during your registration. Options include:

• Science in Progress (In-person or Virtual)
• Nursing Professional Development (In-person Only) – Space is very limited for this breakout. We encourage early registration and ask registrants to ONLY make this selection if you are confirmed to participate in the session in its entirety.

Networking Reception (In-person Only) – In-person attendees are invited to join the Symposium faculty for a networking reception on Friday evening. This event will be held in the lobby of Zuckerman Research Center and RSVP is required. If you are interested in joining the reception, please be sure to select this as an option in your registration. Hors d’oeuvre and refreshments will be served.

SATURDAY, MAY 6

Breakfast Symposium: Chronic Lymphocytic Leukemia (In-person Only) – A special breakfast symposium will be held for in-person attendees on Saturday morning. Space is limited; we ask registrants to ONLY make this selection at registration if you are confirmed to participate.

Luncheon Session: What’s new in Multiple Myeloma (In-person Only) – A special luncheon session will be held at the end of the program on Saturday for in-person attendees. Space is limited for this session; we ask registrants to ONLY make this selection at registration if you are confirmed to participate.

Who Should Attend

The target audience for this Symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma.

1. Describe recent refinements in lymphoma classification
2. Discuss first line treatment options in most frequent lymphoma entities
3. Describe new agents mode of actions, efficacy, side effects
4. Discuss options and recommendations for patients in the relapse refractory setting
5. Provide adequate information to help shared decision with patients regarding their treatment

+ Topics:

Advancing Immune Therapies in Hodgkin Lymphoma.mp4
Advancing Immune Therapies in Hodgkin Lymphoma.pdf
Advancing Immune Therapies in T-cell Lymphoma.mp4
Advancing Immune Therapies in T-cell Lymphoma.pdf
Approaches to Upfront Therapy in T-cell Lymphoma.mp4
Approaches to Upfront Therapy in T-cell Lymphoma.pdf
Bispecific Antibodies- How and When.mp4
Bispecific Antibodies- How and When.pdf
Bispecific Antibodies- Management.mp4
Bispecific Antibodies- Management.pdf
Bispecific Antibodies- Moving the Field Forward.mp4
Bispecific Antibodies- Moving the Field Forward.pdf
CAR T Cell Management.mp4
CAR T Cell Management.pdf
CAR T-cell for Follicular Lymphoma- Success and Limitations.mp4
CAR T-cell for Follicular Lymphoma- Success and Limitations.pdf
CAR T-cell- Success and Limitations.mp4
CAR T-cell- Success and Limitations.pdf
Conquering the Genetic Heterogeneity of Aggressive Lymphomas With Multi-Agent Synergistic Drug Therapy.mp4
Conquering the Genetic Heterogeneity of Aggressive Lymphomas With Multi-Agent Synergistic Drug Therapy.pdf
First Line Therapy- Can We Move the Needle Forward.mp4
First Line Therapy- Can We Move the Needle Forward.pdf
Follicular Lymphoma Roundtable Discussion QA.mp4
From Target to Compounds- BTK.pdf
From Target to Compounds- EZH2.mp4
From Target to Compounds- EZH2.pdf
From Target to Compounds- IDH.mp4
From Target to Compounds- PD1.mp4
From Target to Compounds- PD1.pdf
Hodgkin Lymphoma Roundtable Discussion QA.mp4
Is Standard of Care Still Standard in 1st Line..mp4
Is Standard of Care Still Standard in 1st Line..pdf
Is the Standard of Care in 1st Line Changing.mp4
Is the Standard of Care in 1st Line Changing.pdf
Large B-Cell Lymphoma Roundtable Discussion QA.mp4
Lymphoma Overview- What Is New.mp4
Lymphoma Overview- What Is New.pdf
Lymphoma2023_Brochure.pdf
Managing CLL Recurrence.mp4
Managing CLL Recurrence.pdf
Managing Rare T-cell Lymphomas.mp4
Managing Rare T-cell Lymphomas.pdf
Managing Recurrent Disease.mp4
Managing Recurrent Disease.pdf
Mantle Cell lymphoma Roundtable Discussion QA.mp4
New Agents, New Options.mp4
New Agents, New Options.pdf
New Therapeutic Agents in Lymphoma.mp4
New Therapeutic Agents in Lymphoma.pdf
Newly Diagnosed CLL.mp4
Newly Diagnosed CLL.pdf
Newly Diagnosed Multiple Myeloma.mp4
Newly Diagnosed Multiple Myeloma.pdf
Nursing Professional Development Roundtable Discussion QA.mp4
Radiation Therapy for Localized Stages.mp4
Radiation Therapy for Localized Stages.pdf
Relapsed Multiple Myeloma.mp4
Relapsed Multiple Myeloma.pdf
Science in Progress Roundtable Discussion QA.mp4
Special Session- CAR T cells- Update on Eligibility and Toxicity.mp4
Special Session- CAR T cells- Update on Eligibility and Toxicity.pdf
Special Session- Interpreting Real Life Data.mp4
Special Session- Interpreting Real Life Data.pdf
Special Session- Late Effects of Therapy.mp4
Special Session- Late Effects of Therapy.pdf
Special Session- Lymphoma Classifications- How to Navigate..mp4
Special Session- Lymphoma Classifications- How to Navigate..pdf
T-cell Lymphoma Roundtable Discussion QA.mp4